Evidence map›Paper›PMID 37662251›Full record

ArticlebioRxiv : the preprint server for biology2023

Cell-specific crosstalk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone.

Emily S Norton, Lauren A Whaley, Vanessa K Jones, Mieu M Brooks, Marissa N Russo, Dmytro Morderer, Erik Jessen, Paula Schiapparelli, Andres Ramos-Fresnedo, Natanael Zarco and 8 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Emily S Norton
Lauren A Whaley
Vanessa K Jones
Mieu M Brooks
Marissa N Russo
Dmytro Morderer
Erik Jessen
Paula Schiapparelli
Andres Ramos-Fresnedo
Natanael Zarco
Anna Carrano
Wilfried Rossoll
Yan W Asmann
TuKiet T Lam
Kaisorn L Chaichana
Panos Z Anastasiadis
Alfredo Quiñones-Hinojosa
Hugo Guerrero-Cázares
Mayo Clinic in Florida · USUniversity of North Florida · USJacksonville College · USWinnMed · USW. M. Keck Foundation · US

Funding

Role of the Syx-RhoA signaling axis in glioma cell growth and disseminationR01NS101721 · NINDS · MAYO CLINIC JACKSONVILLE · PI ANASTASIADIS, PANAGIOTIS Z. · 2018 to 2022
$1.4M
Neural stem cells proteomic contribution to glioblastoma malignancyF31NS120605 · NINDS · MAYO CLINIC JACKSONVILLE · PI NORTON-RAMOS, EMILY SHANNON · 2021 to 2022
$85k
NINDS NIH HHS F31 NS120605NINDS NIH HHS R01 NS101721
6 · The paper itself

Abstract

Glioblastoma (GBM) is the most prevalent and aggressive malignant primary brain tumor. GBM proximal to the lateral ventricles (LVs) is more aggressive, potentially due to subventricular zone (SVZ) contact. Despite this, crosstalk between GBM and neural stem/progenitor cells (NSC/NPCs) is not well understood. Using cell-specific proteomics, we show that LV-proximal GBM prevents neuronal maturation of NSCs through induction of senescence. Additionally, GBM brain tumor initiating cells (BTICs) increase expression of CTSB upon interaction with NPCs. Lentiviral knockdown and recombinant protein experiments reveal both cell-intrinsic and soluble CTSB promote malignancy-associated phenotypes in BTICs. Soluble CTSB stalls neuronal maturation in NPCs while promoting senescence, providing a link between LV-tumor proximity and neurogenesis disruption. Finally, we show LV-proximal CTSB upregulation in patients, showing the relevance of this crosstalk in human GBM biology. These results demonstrate the value of proteomic analysis in tumor microenvironment research and provide direction for new therapeutic strategies in GBM. Highlights: Periventricular GBM is more malignant and disrupts neurogenesis in a rodent model.Cell-specific proteomics elucidates tumor-promoting crosstalk between GBM and NPCs.NPCs induce upregulated CTSB expression in GBM, promoting tumor progression.GBM stalls neurogenesis and promotes NPC senescence via CTSB.

Identifiers

PMID37662251
PMCPMC10473635
OpenAlexW4386021867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.